Traumatic Brain Injury Treatment Development

Chairs: Geoffrey Ling, Alan Faden, Reuven Ferziger

TBI is a common disorder in military and civilian populations that has been designated a national priority for treatment development. This session will review our current understanding of the patient with TBI and identify critical translational and clinical research needed to accelerate progress. Methodological issues specific to various stages of clinical development will be addressed, such as patient characteristics and relevant outcome measures, identifying gaps as well as opportunities for enhancement. Learnings that can be applied from clinical research on comorbid psychiatric conditions associated with TBI and other neurological conditions, such as PTSD, headache, sleep disorder and neuroinflamation will be discussed. Regulatory topics of concern will also be addressed.
Return to 11th Annual Scientific Meeting website